Counterfeit Weight Loss Drug Circulates During Clinical Trials

Counterfeit versions of an experimental weight loss drug have entered the black market. This drug remains in clinical trials, meaning regulatory bodies have not yet approved its use or distribution.

Criminal networks are producing and selling these unauthorized versions. They mimic the investigational pharmaceutical, which pharmaceutical companies are developing for weight management.

The distribution of these fake medications occurs outside of regulated channels. This practice circumvents the established procedures for drug approval and patient safety.